Euractiv (Advocacy Lab)
EU Perspectives
European Biotechnology Magazine
APM Market Access
EU PERSPECTIVES - Two European Parliament committees have moved to delete the Biotech Act's most contested measure: a proposed 12-month extension of market protection for biotech medicines. Read more
EU PERSPECTIVES - Cardiovascular disease kills around 1.7 million Europeans every year, yet the EU has never had a dedicated strategy to tackle it. That is now changing with the Safe Hearts Plan. But as lawmakers backed the initiative on Wednesday, its parliamentary rapporteur warned that the final compromise fell short of her ambitions on tobacco...
EURACTIV - Dementia experts from 12 countries have signed a policy paper urging Brussels to give dementia its own framework, modelled on the €4 billion Beating Cancer Plan. Read more
EU PERSPECTIVES - Patients could pay the price as MEPs vote to delay who foots the bill for cleaning Europe's water. Parliament backed a temporary suspension of new costs for drugmakers and cosmetics firms. The vote split the assembly, pitting fears of medicine shortages against warnings that citizens will pay for pollution instead. Read more
